Am. J. Respir. Crit. Care Med., Volume 156, Number 2, August 1997, 583-590

Significance of the Isolation of Candida Species from Respiratory Samples in Critically Ill, Non-neutropenic Patients
An Immediate Postmortem Histologic Study

MUSTAFA EL-EBIARY, ANTONI TORRES, NEUS FÁBREGAS, JORGE PUIG de la BELLACASA, JULIÁ GONZÁLEZ, JOSEP RAMIREZ, DOLORES del BAÑO, CARMEN HERNÁNDEZ, and M. T. JIMÉNEZ de ANTA

Serveis de Pneumologia i Al.lèrgia Respiratòria, Anestesia, Microbiologia, Anatomia Patologica, Hospital Clínic, Departament de Medicina, Universitat de Barcelona, Spain

The diagnosis of pulmonary candidiasis is still controversial. We undertook a prospective study on 25 non-neutropenic, mechanically ventilated (> 72 h) patients who died in our ICU with the aim of assessing the incidence and significance of the isolation of Candida species from quantitative cultures of immediate postmortem lung biopsies and different respiratory sampling techniques. Immediate postmortem respiratory samples (endotracheal aspirate, protected specimen brush [PSB], bronchoalveolar lavage [BAL], blind biopsies [average 14/patient], and bilateral bronchoscopically guided biopsies [two per patient]) were taken from all patients. Lung tissue specimens were histologically examined. Respiratory samples were classified as having Candida or otherwise. Ten (40%) patients had at least one pulmonary biopsy yielding Candida spp. Among these 10 patients with Candida isolates, only two had definite pulmonary candidiasis. A total of 470 microorganisms were isolated from 280 of 375 (77%) lung biopsy samples in all 25 patients. Candida species represented 9% (n = 40) of the isolates, corresponding to 10 patients (40%). In the 10 patients in whom Candida species was isolated from pulmonary biopsies, this was always associated with the isolation of the same microorganism from one of the sampling methods. Quantitative cultures of Candida species from different sampling methods correlated well among each other but could not discriminate the presence from absence of Candida pneumonia. A logistic regression model adjusted for the presence of antibiotics, days of antibiotic treatment, mechanical ventilation period, age, ARDS, parenteral nutrition, and gender did not show any independent risk factor for developing positive pulmonary samples for Candida species. The incidence of Candida isolation from pulmonary biopsies in critically ill mechanically ventilated, non-neutropenic patients who die is high (40%). However, the incidence of definite Candida pneumonia was 8%. We also found that Candida colonization is uniform throughout the different lung regions, and that the presence of Candida in respiratory samples, independently of quantitative cultures, is not a good marker of Candida pneumonia in critically ill, non-neutropenic, non-AIDS patients. El-Ebiary M, Torres A, Fàbregas N, de la Bellacasa JP, González J, Ramirez J, del Baño D, Hernández C, Jiménez de Anta MT. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients: an immediate postmortem histologic study.

This article has been cited by other articles:

				S. M. Koenig and J. D. Truwit Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention Clin. Microbiol. Rev., October 1, 2006; 19(4): 637 - 657. [Abstract] [Full Text] [PDF]

				E. Azoulay, J.-F. Timsit, M. Tafflet, A. de Lassence, M. Darmon, J.-R. Zahar, C. Adrie, M. Garrouste-Orgeas, Y. Cohen, B. Mourvillier, et al. Candida Colonization of the Respiratory Tract and Subsequent Pseudomonas Ventilator-Associated Pneumonia Chest, January 1, 2006; 129(1): 110 - 117. [Abstract] [Full Text] [PDF]

				Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416. [Full Text] [PDF]

				E. J. Anaissie, T. H. Mahfouz, T. Aslan, A. Pouli, R. Desikan, A. Fassas, and B. Barlogie The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management Blood, March 1, 2004; 103(5): 1611 - 1617. [Abstract] [Full Text] [PDF]

				L. Tan, X. Sun, X. Zhu, Z. Zhang, J. Li, and Q. Shu Epidemiology of Nosocomial Pneumonia in Infants After Cardiac Surgery Chest, February 1, 2004; 125(2): 410 - 417. [Abstract] [Full Text] [PDF]

				J. Barenfanger, P. Arakere, R. D. Cruz, A. Imran, C. Drake, J. Lawhorn, S. J. Verhulst, and N. Khardori Improved Outcomes Associated with Limiting Identification of Candida spp. in Respiratory Secretions J. Clin. Microbiol., December 1, 2003; 41(12): 5645 - 5649. [Abstract] [Full Text] [PDF]

				A. S. Michalopoulos, S. Geroulanos, and S. D. Mentzelopoulos Determinants of Candidemia and Candidemia-Related Death in Cardiothoracic ICU Patients Chest, December 1, 2003; 124(6): 2244 - 2255. [Abstract] [Full Text] [PDF]

				C. Agusti, A. Rano, X. Filella, J. Gonzalez, A. Moreno, A. Xaubet, and A. Torres Pulmonary Infiltrates in Patients Receiving Long-term Glucocorticoid Treatment: Etiology, Prognostic Factors, and Associated Inflammatory Response Chest, February 1, 2003; 123(2): 488 - 498. [Abstract] [Full Text] [PDF]

				J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF]

				M. B. Feinstein, M. Mokhtari, R. Ferreiro, D. E. Stover, and A. Jakubowski Fiberoptic Bronchoscopy in Allogeneic Bone Marrow Transplantation : Findings in the Era of Serum Cytomegalovirus Antigen Surveillance Chest, October 1, 2001; 120(4): 1094 - 1100. [Abstract] [Full Text] [PDF]

				J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia Chest, September 1, 2001; 120(3): 955 - 970. [Abstract] [Full Text] [PDF]

				S. Natsch, M. H. M. Steeghs, Y. A. Hekster, J. F. G. M. Meis, J. W. M. van der Meer, and B. J. Kullberg Use of fluconazole in daily practice: still room for improvement J. Antimicrob. Chemother., August 1, 2001; 48(2): 303 - 310. [Abstract] [Full Text] [PDF]

				K.-Y. Chen, S.-C. Ko, P.-R. Hsueh, K.-T. Luh, and P.-C. Yang Pulmonary Fungal Infection : Emphasis on Microbiological Spectra, Patient Outcome, and Prognostic Factors Chest, July 1, 2001; 120(1): 177 - 184. [Abstract] [Full Text] [PDF]

				Members of the Task Force:, E. Bouza, C. Brun-Buisson, J. Chastre, S. Ewig, J-Y. Fagon, C.H. Marquette, P. Munoz, M.S. Niederman, L. Papazian, et al. Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet Eur. Respir. J., May 1, 2001; 17(5): 1034 - 1045. [Full Text] [PDF]

				A Rañó, C Agustí, P Jimenez, J Angrill, N Benito, C Danés, J González, M Rovira, T Pumarola, A Moreno, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures Thorax, May 1, 2001; 56(5): 379 - 387. [Abstract] [Full Text]

				C. Mayaud and J. Cadranel A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host Thorax, June 1, 2000; 55(6): 511 - 517. [Full Text]

				P. E. Marik Fever in the ICU Chest, March 1, 2000; 117(3): 855 - 869. [Abstract] [Full Text] [PDF]